Trials / Conditions / Metastatic Malignant Neoplasm in the Lung

Metastatic Malignant Neoplasm in the Lung

21 registered clinical trials studyying Metastatic Malignant Neoplasm in the Lung — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the NCT05717140	Mayo Clinic	Phase 1
Recruiting	Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspec NCT06482073	Mayo Clinic	—
Recruiting	Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Tre NCT05802186	Northwestern University	N/A
Recruiting	Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunot NCT05039632	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Recruiting	Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma NCT05235165	Children's Oncology Group	Phase 3
Withdrawn	Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage NCT04987281	M.D. Anderson Cancer Center	Phase 2
Recruiting	Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases NCT03965234	Roswell Park Cancer Institute	Phase 1 / Phase 2
Completed	Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Canc NCT03749460	University of Washington	Phase 1 / Phase 2
Recruiting	Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery NCT03582124	Stanford University	Phase 1 / Phase 2
Recruiting	Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patient NCT03422302	M.D. Anderson Cancer Center	N/A
Active Not Recruiting	First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide NCT03164486	Julie L. Sutcliffe, Ph.D	EARLY_Phase 1
Terminated	Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be R NCT02738606	M.D. Anderson Cancer Center	Phase 2
Completed	Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma NCT02484443	National Cancer Institute (NCI)	Phase 2
Completed	CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Meta NCT02693080	Stanford University	Phase 1
Completed	Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival NCT02364557	NRG Oncology	Phase 2 / Phase 3
Active Not Recruiting	Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing NCT02306161	National Cancer Institute (NCI)	Phase 3
Completed	Proton Beam Re-Irradiation in Thoracic Cancers NCT02204761	University of Washington	N/A
Terminated	Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy NCT02062632	Mayo Clinic	Phase 2
Active Not Recruiting	Aerosolized Aldesleukin in Treating Patients With Lung Metastases NCT01590069	M.D. Anderson Cancer Center	Phase 1
Completed	4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis NCT00862680	M.D. Anderson Cancer Center	—
Completed	Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis NCT01014598	Roswell Park Cancer Institute	Phase 1